Home
Who we are
Pipeline
News
Contact
Our mission is to develop essential medicines to improve
care and support of pediatric orphan diseases.
ORPHELIA Pharma
is a biopharmaceutical company dedicated to the development and marketing of pediatric drugs in oncology and neurology.
Latest news and reports
Latest news and report
10 décembre 2019
Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma
Read more
9 décembre 2019
ORPHELIA Pharma recrute un/une Assistant(e) administrative, commercial(e) et comptable
Read more
9 décembre 2019
ORPHELIA Pharma recrute un/une Medical Science Liaison France et Europe
Read more
9 décembre 2019
ORPHELIA Pharma recrute un/une Responsable marchés publics France et Europe
Read more
26 novembre 2019
Granting of the Marketing Authorisation for Ivozall
Read more
29 octobre 2019
ORPHELIA Pharma will be present at CPhI in Frankfurt
Read more
29 octobre 2019
License and distribution agreement for Kigabeq in the United Kingdom
Read more
22 octobre 2019
ORPHELIA at the Rare Diseases Meeting Days
Read more
